carbenoxolone sodium has been researched along with glycogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bracht, A; Constantin, J; Ishii-Iwamoto, EL; Suzuki-Kemmelmeier, F; Yamamoto, NS | 1 |
| Acharya, V; Ayyalasomayajula, V; Koppala, SR; Nemani, H; Ponday, LR; Pothana, S; Prasad Sakamuri, SS; Prathipati, VK; Putcha, UK; Sukapaka, M; Veetill, GN | 1 |
2 other study(ies) available for carbenoxolone sodium and glycogen
| Article | Year |
|---|---|
The action of glucagon infused via the hepatic artery in anterograde and retrograde perfusion of the rat liver is not a function of the accessible cellular spaces.
Topics: Animals; Calcium; Carbenoxolone; Cell Communication; Cyanides; Extracellular Space; Glucagon; Gluconeogenesis; Glucose; Glycogen; Hepatic Artery; Hepatic Veins; Lactates; Liver; Male; Oxygen Consumption; Perfusion; Portal Vein; Rats; Rats, Wistar | 1995 |
Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adipose Tissue; Adrenal Glands; Animals; Body Composition; Carbenoxolone; Cholesterol, HDL; Corticosterone; Eating; Enzyme Inhibitors; Fibrosis; Gene Expression Regulation; Glucose Intolerance; Glycogen; Hypertrophy; Liver; Male; Metabolic Syndrome; Obesity; Organ Size; Rats; Signal Transduction; Thinness; Triglycerides | 2012 |